Andrea Moir

Bridging in vitro dissolution and in vivo exposure for acalabrutinib. Part II. A mechanistic PBPK model for IR formulation comparison, proton pump inhibitor drug interactions, and administration with acidic juices

Xavier Pépin, Andrea Moir, James Mann et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2019 · 49 citations

Pharmaceutical Science, Vivo Exposure, Biochemistry +7

A comparative study of the allomerization reaction of chlorophyll a and bacteriochlorophyll a

Paul S. Woolley, Andrea Moir, Ronald E. Hester et al. · Journal of the Chemical Society Perkin Transactions 2 · 1998 · 47 citations

Bioorganic Chemistry, Engineering, Molecular Biology +18

IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies

Xavier Pépin, Leon Aarons, Yuya Wang et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2020 · 36 citations · Full text

Pharmacokinetic Modeling, Prediction Accuracy, Modelling Strategies +9

Evaluating the impact of acid-reducing agents on drug absorption using biorelevant in vitro tools and PBPK modeling - case example dipyridamole

Domagoj Šegregur, Richard A. Barker, James Mann et al. · European Journal of Pharmaceutical Sciences · 2021 · 15 citations

Acid-reducing Agents, Vitro Tools, Pharmaceutical Science +8

Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series

Mark McAllister, Talia Flanagan, Susan Cole et al. · Pharmaceutics · 2022 · 14 citations · Full text

Pharmaceutical Science, Pharmaceutical Research, Bioequivalence +14